Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Interest Income | 319,761 | 214,727 | 197,313 | 201,385 | 205,310 |
| Interest Expense | 122,945 | 89,807 | 96,965 | 116,516 | 125,544 |
| Interest Income (Net of Interest Expense) | 196,816 | 124,920 | 100,348 | 84,869 | 79,766 |
| Non-Interest Income | 47,799 | 33,735 | 29,080 | 21,021 | 14,488 |
| Sales | 244,615 | 158,655 | 129,428 | 105,890 | 94,254 |
| Credit Losses Provision | 12,150 | 10,500 | 11,867 | 8,000 | 4,600 |
| Non Interest Expenses | 148,370 | 94,564 | 80,943 | 73,293 | 67,968 |
| Pre-tax Income | 84,095 | 53,591 | 36,618 | 24,597 | 21,686 |
| Income Tax | 27,790 | 18,678 | 11,031 | 8,409 | 8,033 |
| Other Income | 207,040 | 143,398 | 133,583 | 141,113 | 147,230 |
| Net Income | $56,305 | $34,913 | $25,587 | $16,188 | $13,653 |
| EPS Basic Continuous Ops | 109.17 | 95.78 | 78.31 | 53.32 | 45.91 |
| EPS Basic Total Ops | 109.21 | 95.39 | 78.51 | 53.43 | 46.03 |
| EPS Diluted Continuous Ops | 106.72 | 93.41 | 76.11 | 52.20 | 45.68 |
| EPS Diluted Total Ops | 106.58 | 93.42 | 76.32 | 52.23 | 45.67 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |